• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018
  • New Vizit Bibliography pane January 8, 2018
  • Share to Weibo added to Biovista Vizit October 25, 2017

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

Multiple Sclerosis

Role of the Microbiome in Multiple Sclerosis

September 24, 2018Microbiome, Multiple Sclerosis, Nervous System Disorders, Vizit Graphs
Role of the Microbiome in Multiple Sclerosis

Could Multiple Sclerosis be linked to the Microbiome? Use Biovista Vizit, a brainstorming tool for scientists. Explore the live graph.

Repurposing Pirlindole for Multiple Sclerosis

August 24, 2018Featured, Multiple Sclerosis, Nervous System Disorders, Vizit Graphs
Repurposing Pirlindole for Multiple Sclerosis

Mechanism of action of Pirlindole in Multiple Sclerosis. Explore the live graph.

Vizit Graphs Tag Cloud

LISTERIA MONOCYTOGENES FOXP3 INFLAMMATION APOPTOTIC PROCESS CANCER CANDIDA ALBICANS ALZHEIMER'S DISEASE DOXORUBICIN REMICADE CELL DIVISION CASP3 SOD1 INSULIN CELL PROLIFERATION IL6 PORPHYROMONAS GINGIVALIS 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE TH17 CELLS IL23A STAPHYLOCOCCUS AUREUS ERBB-2 AUTOPHAGY TP53 PSEUDOMONAS AERUGINOSA RHEUMATOID ARTHRITIS CELL DIFFERENTIATION AGING STREPTOCOCCUS PNEUMONIAE METFORMIN BREAST CANCER NEURODEGENERATIVE DISORDERS RECEPTOR IMMUNE RESPONSE CD4 HELICOBACTER PYLORI PARKINSON DISEASE ESCHERICHIA COLI TNF IL17A IFNG DIABETES MELLITUS CTLA4 CELL DEATH CLOSTRIDIUM DIFFICILE ANGIOGENESIS

© 2019 Biovista Vizit All Rights Reserved.